Are Peptides Regulated in the UK?

Which UK law treats a peptide as a medicine?

A peptide is treated as a medicine in the UK when it is presented, or functions, as one. The Human Medicines Regulations 2012 (SI 2012/1916) define a "medicinal product" to include any substance administered to a person with a view to restoring, correcting, or modifying a physiological function, or presented as having properties for treating or preventing disease. Peptide drugs are a well-established and growing class under that definition: a widely cited pharmacology review reported approximately 140 peptide therapeutics being evaluated in clinical trials at the time of writing (Fosgerau & Hoffmann, Drug Discovery Today, 2015, PMID 25450771). Where a peptide meets that medicinal-product test, it needs an MHRA marketing authorisation before it can be lawfully supplied for human use in the UK, and its manufacture must happen under a Manufacturer's Licence to Good Manufacturing Practice standards. The MHRA's public register of authorised medicines, available through gov.uk/MHRA, is the authoritative source for whether a specific licensed peptide medicine exists for a given indication.

Are growth-hormone peptides a controlled substance in the UK?

Growth hormone itself, yes, separately from medicines law. Schedule 2 of the Misuse of Drugs Act 1971 lists somatropin, somatrem and somatotropin in Class C, alongside anabolic steroids, chorionic gonadotrophin and clenbuterol (Schedule 2, Part 3). The schedule names specific substances, so other growth-hormone-related peptides are not controlled drugs simply by that association; their status depends on the exact compound and on medicines law. Where a substance is controlled, unlawful production, supply and importation are criminal offences, and the Act and the Misuse of Drugs Regulations 2001 set the detail, so check the current text rather than relying on a summary. The controlled-drug layer is additional to the medicines regime: an unlicensed medicine can also be a controlled drug at the same time.

Are peptides used in skincare regulated the same way?

No. Cosmetic peptides sit in a separate regime entirely. Peptide ingredients used in anti-ageing skincare, such as signal peptides and carrier peptides formulated into creams and serums, are regulated as cosmetic products under the UK Cosmetic Regulation (the retained version of EU Regulation 1223/2009 as it applies in Great Britain), not as medicines. The regime is overseen by the Office for Product Safety and Standards (OPSS) and enforced locally by Trading Standards, and the compliance route runs through a Cosmetic Product Safety Report and notification on the UK's cosmetic product notification system, a materially different process from an MHRA marketing authorisation. This split matters for a simple reason: the word "peptide" on a product label tells you nothing about which regulator, if any, has assessed it, or under which legal standard.

Are peptides banned in sport in the UK?

For athletes subject to testing, yes, a defined category is. UK Anti-Doping (UKAD) is the national organisation responsible for enforcing the World Anti-Doping Agency (WADA) Prohibited List in the UK. Section S2 of that list, "Peptide Hormones, Growth Factors, Related Substances and Mimetics," prohibits a range of peptide hormones and growth factors both in and out of competition for athletes who fall under a sport's testing jurisdiction. This prohibition operates independently of a peptide's status under medicines or controlled-drugs law: a peptide can be lawful to possess for personal, non-sporting use and still result in a doping violation for a tested athlete who uses it.

Does the MHRA approve or certify individual peptide sellers?

No. The MHRA licenses specific medicinal products and the manufacturing sites that produce them; it does not certify, approve, or endorse individual sellers or suppliers as a category. A claim that a seller is "MHRA-approved" or "MHRA-registered," made in general terms rather than naming a specific licensed medicine the MHRA has actually authorised, is not something the agency's framework supports. The only verifiable question is narrower and more useful: does this specific product, in this specific form, hold a current marketing authorisation on the MHRA's public register. That is a question about the product and never a blanket endorsement of who is selling it.

What is the status of a peptide with no UK marketing authorisation?

It falls outside the Human Medicines Regulations 2012 and into the category the MHRA treats as unlicensed for human use. That status is the default position for most peptides sold for laboratory or research purposes: no independent safety and efficacy review has taken place, no Good Manufacturing Practice oversight applies, and supply for human use can trigger MHRA enforcement regardless of how the product is labelled. Unlicensed status is not automatically the same as controlled-drug status. The two regimes are separate, and only substances named in the Misuse of Drugs Act schedules, such as growth hormone, carry that additional classification.

Why "regulated" is the wrong single question

Asking whether peptides are regulated in the UK assumes a single answer exists. In practice, the honest answer sorts a peptide into one or more of four separate regimes: medicines law for anything presented or functioning as a medicine, the Misuse of Drugs Act for named controlled substances such as growth hormone, cosmetic product law for topical skincare ingredients, and anti-doping rules for tested athletes. A given peptide's position in each of those regimes can be checked independently — against the MHRA's product register, against the schedules of the Misuse of Drugs Act 1971, against OPSS cosmetic notification requirements, or against the current WADA Prohibited List, and none of those checks substitutes for the others.

Summary: four regimes, not one

Peptides are regulated in the UK, but across four distinct frameworks rather than a single peptide-specific law. A peptide marketed as a medicine answers to the MHRA under the Human Medicines Regulations 2012. Growth hormone answers additionally to the Home Office under the Misuse of Drugs Act 1971, as a Class C controlled drug. Peptides formulated into cosmetics answer to OPSS under UK cosmetic product law. And peptide hormones on the WADA Prohibited List answer to UK Anti-Doping for any athlete subject to testing. Checking a specific peptide's status means checking it against the regime that actually applies to it, not assuming one blanket rule covers every use.